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SUMMARY
Guidance on the prevention ofhyponatraemia in children was issued by DHSSPSNI in March 2002.
Two years later Dr Henrietta Campbell, the ChiefMedical Officer, wrote to the ChiefExecutives of
acute and combined trusts to seek assurances that the guideline had been incorporated into clinical
practice and its implementation monitored. This paper reports the findings ofthe first prospective
study undertaken to examine practice following introduction ofthe guidance. The evidence suggests
that implementation has so far been incomplete and highlights problem areas.The paper reflects on
potential explanations for the findings and makes practical suggestions for improvement.
INTRODUCTION
In November 2004, following the broadcast ofthe
UTV Insight programme 'When Hospitals Kill'
allegingthatthree children haddiedunnecessarily,
the Minister with responsibility for Health,
Social Services and Public Safety, Angela Smith
announcedthatshehadappointedMrJohnO'Hara
QC, to lead an inquiry into their hyponatraemia-
relateddeaths.Examinationofthecareandtreatment
inrelationtothemanagementoffluidbalanceandthe
choice andadministrationofintravenousfluidswill
beakeycomponentoftheInquiryinallthreecases.
Earlierinthe sameyearDrHenriettaCampbell, the
ChiefMedical Officer (CMO), had written to the
ChiefExecutivesofacuteandcombinedtruststoseek
assurances thatthe guidance issuedby DHSSPSNI
in 2002 on the prevention of hyponatraemia in
children receiving prescribed fluids' had been
both implemented and incorporated into clinical
practice. In2003,topromotefurtherawarenessand
also to elaborate on the rationale underpinning the
guideline,Jenkinsandcolleagues2inanEditorialin
thisjournalhighlightedtheclinicalsituationswhere
children are atgreatestriskfordeveloping elevated
vasopressinlevels,describedassociatedriskfactors
anddiscussedhowthechoiceofprescribedfluidscan
contributetodilutionalhyponatraemia. Specifically
the guideline recommends 0.9% saline as an
appropriatecrystalloidforresuscitation;directsthat
theanticipatedNa+,K+andglucoserequirements,for
which age is an essential factor, should determine
the type ofmaintenance fluidandproposes that for
most replacement scenarios fluid with minimum
sodium content 130mmol/I should be used. Also
incorporated is advice on patient assessment that
includes checking the weight ofthe child; advice
on how to calculate fluid requirements and details
oftheclinicalandbiochemicalmonitoringrequired
while in receipt ofIV fluids.
Inresponsetothe CMO'srequestforassurancethat
theguidancehadbeenimplementedtheprospective
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study described in this paper, the first to examine
guideline adherence in local paediatric units, was
undertaken to examine practice andto identify any
component(s)presentingimplementationdifficulty
andifpresentto inturnreflectonpossiblepractical
solutions.
METHODS
All eight acute paediatric inpatient units in
Northern Irelandwere invitedbyone ofthe authors
(JMA), through a lead clinician, to participate in
a simultaneous snapshot of paediatric practice
around the Province and readily accepted. It was
proposed that the management of all patients in
receipt of intravenous (IV) fluids between 12.00
and 14.00hrs on the same day in May 2003, and
who had also been in receipt of IV fluids in the
previous twenty-four hours, would be assessed for
compliance with the guidance. This time window
was chosen inthe expectation that amorning ward
roundwouldnormallybythenhavebeenconducted,
thus providing a pragmatic method oftargeting a
high risk group requiring ongoing therapy post
baseline assessment and for whom there would
have been adequate opportunity for management
plans, monitoring and associated decision making
to have been put in place. Neonates and intensive
carepatients,whosemanagement isdifferent, were
excluded. Theleadclinicians were askedto inform
the relevant Clinical Director(s) thatthe study was
beingplanned; askedtoidentifyamedicalassistant
for local data collection and to ensure thatthe date
was kept confidential in order to avoid a positive
influence on clinician behaviour. To facilitate
maximumparticipationcoordinatorswerereminded
ofthe study date in the preceding week. The same
singlepagedatacollectionform,previouslypiloted
andrefinedbyapaediatricSHO(RK)duringtwoone
week trial periods atAntrim Hospital, was used in
eachcontributingunit. Detailsofdiagnosis,presence
ofdehydration,weightrecording,fluidprescription
and clinical and biochemical monitoring were
transcribed from the case notes, fluid prescription
and fluid balance sheets.
Details of the specific elements involved in
monitoring, such as records ofurinary output and
vomiting were, forpractical reasons, not included.
Instead it was assumed that a documented record
of any reassessment of requirements indicated
that assessment of all the key components had
occurred.
Consistency ofdata interpretation for the purpose
of comparing actual management with expected
guideline management was facilitated by having
the same experienced clinician (JMA) analyse the
returneddataformsandcrossreferencethediagnosis
and assessment offluid balance status against the
record ofprescription for each individual patient.
Also, when the adequacy ofdata return permitted
all calculations of fluid volumes prescribed were
recalculated by JMA. To facilitate collation of
information a prescription for maintenance fluids
wasjudged to be inconsistent with the guideline if
the volume prescribedwas greaterthan+/- 5% and
inappropriateifgreaterthan+/-10%oftheguideline
calculation. The rationale forthispercentage limit
is that in terms ofdegrees ofdehydration a larger
variationcouldcorrespondtoincorrectmanagement
e.g. treating a moderately dehydrated patient for
mild dehydration or vice versa.
As the recruitable numbers able to satisfythe strict
inclusion criteria were small an identical exercise
wasrepeated ontwo furtherdays, one inJune 2003
and one in January 2004.
RESULTS
There were thirty-eight eligible children forwhom
forms with complete/near complete data were
returned. Allunits contributed at least onepatient.
Twenty-six children had a medical diagnosis and
twelve had a surgical problem, eight of whom
were in the post operative period. Four children
had conditions for which not all elements of the
guidance were relevant (see sections b, e). The
grades of staffprescribing the fluids were PRHO
(4);firsttermSHO(19); secondtermSHO(5); SpR
(5); SAS (1); consultant(3)withoneunknown.The
results foradherence to eachkey component ofthe
guidelinearedescribedbelowwiththemainfindings
summarised in table 1.
a. Was the child's weight recorded?
Data were returned for thirty-five children.
Weightwasmeasuredin33 casesandestimated
in 2.
b. Was the calculation for maintenance IV fluid
volume consistent with the guidance?
Of the thirty-seven children with this data
returnedthereweretwochildrenreceivingfluid
treatment in association with chemotherapy
and one with adiagnosis ofbenign intracranial
hypertension in whom an alternative protocol
wasbeingfollowedandforwhomtheguideline
maintenance calculation was not applicable.
Eighty-two percent ofrelevant calculations
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TABLE I
Guideline adherence question Total yes no
b. was maintenance calculation consistent with guidance? 34 28 6
c. was IV fluid composition appropriate? 35 35 0
d. were maintenance & replacement prescribed separately 7 2 5
e. was fluid balance assessed at least 12 hourly? 33 15 18
f. was U&E checked at least once per 24 hours? 34 30 4
g. was oral intake considered in IV prescription? 23 12 11
Adherence to DHSSPSNI guidance' on prescribed fluids and hyponatraemia
were consistent with the guidance. There were
threecalculationsjudgedguidelineinconsistent
and three othersjudged inappropriate.
c. Was the composition of IV fluids used
appropriate?
Datawere returned forthirty children who had
received either maintenance fluids alone or
both resuscitation and maintenance fluids plus
five other children who also had aprescription
for replacement and/or ongoing losses. The
electrolyte and glucose content of the fluid
utilised was suitable in all thirty-five cases.
d. Were maintenance and replacement fluids
prescribed separately?
Thereturnforthisquestionprovidedinformation
onafurthertwochildreni.e.atotalofseven,who
had both maintenance and replacement losses
prescribed. Two ofthe seven hadreplacement
prescribed separately but five did not.
e. Was fluidbalance assessed at least every twelve
hours?
Of thirty-seven data returns the guidance was
considered applicable only to thirty-three as
threewerefollowinganalternativefluidregimen
and one was terminally ill. Forty-five percent
had documented evidence of reassessment
of requirements in the first twelve hours of
treatment. Sixty-six percent had reassessment
withinthe firsttwenty-fourhours. Thirty-three
percent had no record ofreassessment.
f. Was U&E checked at least once per twenty-
fours?
There were thirty-four data returns for whom
the guidance was applicable. Twelve percent
had not had a U&E checked any time in the
preceding 24 hours. There were no children
with severe hyponatraemia (Na+ <13Ommol/l)
thoughnine childrenhadaNa+ <135mmol/l at
some point.
g. Wasthe oralfluidintake consideredinthemost
recent IV fluidprescription?
Allowance for oral intake occurred in only
fifty-two percent of the twenty-three children
for whom the guidance was relevant.
h. What oral fluids were used during this period?
Information was provided for seventeen ofthe
twenty-threetreatedwithbothoralandIVfluids
and is summarised in table 2.
Table II
Fluidtype n
Water 2
water andjuice 4
water and soup 1
Juice 2
juice and milk 1
Milk 5
rehydration solution 2
Types oforal fluid administered concurrently with
IV fluids
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DISCUSSION
While the number of children in the study was
inevitablysmalltheinformationobtainedshouldbe
avalidreflectionofclinicalpracticefollowingissue
oftheguidanceanditisconsequentlyimportant. As
the study period included three induction periods
for new/ changing medical staffit is reasonable to
conclude that there was sufficient opportunity for
the guideline to be both fully disseminated and
introduced. Also the patients reported were those
with the highest risk of fluid therapy associated
complications for whom greatest awareness and
attention to the application of the management
guidelines would be expected.
The standard for weight, namely that it should
always be measured or estimated in a bed bound
child, was met. However this may not necessarily
reflect guideline conscious behaviour as recording
of weight has become part of normal paediatric
practice regardless ofdiagnosis.
Thestandardachievementrate(82%)formaintenance
fluidcalculationwasalsohighbutwithsomeevidence
oftheco-existenceofpotentiallysignificantvariation
from advised practice. Jenkins and colleagues2
acknowledge that guidance on maintenance fluid
requirements is general guidance and emphasise
that assessment should be individualised. We
allowedforthisinourevaluationbyaccepting atotal
calculated volume within +/- 5% ofthe guideline
value as meeting the standard. Ofthe six children
whose calculation was outside the guideline there
were three whose prescriptions were classified as
inappropriate,twobeingunderestimatesandthethird
an overestimate. The two underestimates were in a
fifteenyearold(-17%)onday 1postappendicectomy
with afirstterm SHO asprescriberandin athirteen
yearold(-19%)withurinaryinfectionandprescriber
notindicated. Theoverestimatedchildwas asixyear
old(+27%)admittedwithvomitingandconstipation
butnodehydrationandforwhomtheprescriberwas
a first term SHO. The management ofhis child is
ofconcern though close monitoring did take place
with the U&E checked on four occasions and the
lowest Na+ recorded was 134mmol/l.
Whiletherewasfullcomplianceinimplementingthe
standardforappropriatefluidchoiceproblems were
encountered at the next step, namely recording the
prescription. Aseparateprescriptionformaintenance
andreplacementfluidsisrecommendedtoreducethe
potentialriskofexcessfluidadministrationresulting
from a combined prescription inadvertently over
runningthedeficitcorrectionperiod. Separationof
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the prescriptions did not occur in seventy percent
ofrelevant situations. While this may reflect lack
ofclinicalawareness, anotherfactormaybe lackof
user friendliness ofavailable prescription sheets.
Monitoring ofhydration status and fluidbalance is
essential. Theguideline specifiesthatreassessment
should occur at least twelve hourly but this was
onlyrecordedintheminorityofcases. Itisunlikely
thatthis finding is attributable more to poorrecord
keeping than lack of reassessment as there were
four children identified who had no U&E checked
during twenty-four hours of IV therapy, three of
whomhadactuallybeenonfullmaintenance.These
three included two post-operative, hence relatively
highrisk, patients aged 6weeks and 11 years anda
8 year old with septic arthritis. The rigour ofsome
assessmentsisalsoofconcernas,contrarytoadvice,
noconsiderationhadbeenallowedfortheoralintake
infiftypercent ofrelevantprescriptions.
The guidance mentions hyponatraemic risk in
associationwithuseofinappropriateoralfluidsbut
there were only two children whose oral fluid was
a commercial rehydration solution (Table 1). The
prevalent use of hypotonic solutions in this high
riskgroup suggests that commonpractice needs to
be reviewed.
Insummarythe evidence is thatimplementationof
the Regional guidance has so farbeen incomplete.
Thiscouldindicatethatthereisinadequateguideline
awareness due to failure of training programmes
and/orfailureofunitstoprovidedirectiontojunior
staff. Analternativeexplanationisthattheremaybe
intrinsicoperationalhindrancestoimplementingthe
guideline.Ifnotdonealready,unitsshouldorganise
a review by nursing, pharmacy and medical staff,
bothjuniorandsenior,toidentifythedifficultiesand
possiblesolutions.Relevantissuesfordiscussionand
action could include: the redesign ofprescription
sheetstofacilitateseparationofprescriptionswhen
only one IV infusion/line is present; the facility
to indicate required infusion finish times; the
provision of action boxes on fluid balance sheets
to trigger clinical and biochemical reassessments;
appending for reference a simplified maintenance
fluidcalculationformulaonthebackofprescription
sheets;outliningclinicaldescriptionsforassessment
ofhydrationstatusonthebackoffluidbalanceforms;
provision of oral fluid management information
and advice for carers and the introduction of a
methodforeffectivenursing andmedicalhandover
ofmanagementplans for all children receiving IV
fluids. Redrafted or new documentation could be
www.ums.ac.uk
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standardised inalltrusts andaconsensus shouldbe
developed onthe appropriateuse ofhypotonic oral
fluids with the original guideline Working Group
providing a strategic overview.
Toconclude,itisprobablethatthecurrentguidelines
willbemodifiedinconjunctionwiththedeveloping
evidence base on appropriate fluid therapy in
situations where physiology is not normal, such
as illness or postoperatively. Internationally best
practice is still controversial3'4 and preparation
of definitive protocols is not yet possible, unlike
hyperkalaemia where a consensus is now being
reached.' Untilthenitis essential thatall clinicians
inNorthern Irelandcaringforchildren inreceiptof
fluid therapy know ofthe associated risks and are
aware ofour Regional best practice guidance and
that paediatric departments initiate a process of
regularmonitoringofguidanceadherenceaspartof
theirmultidisciplinaryauditandclinicalgovernance
programme.
TheAuthors have no conflict ofinterest.
ACKNOWLEDGEMENTS
The willing collaboration of Mr A Bailie, Drs A Bell, C
Corkey, N Corrigan, J O'Donohoe, M Rollins, M Smith in
arrangingthe datacollection is acknowledged. Thanks to Dr
J Jenkins forreviewing thepaper andhis helpful suggestions
for improvement.
REFERENCES
1. DHSSPS. Published information: hyponatraemia wall
chart. 2002. Available from URL:
http://www.dhsspsni.gov.uk/publications/2002/
Hypno%2OWallChart.pdf
2. Jenkins J, Taylor B, McCarthy M. Prevention of
hyponatraemiainchildrenreceivingfluidtherapy. Ulster
MedJ2003; 72(2): 69-72.
3. DukeT, Molyneux E. Intravenous fluids for seriously ill
children: time to reconsider. Lancet 2003; 362(9392):
1320-23.
4. MoritzM,AyusJ. Hospital-acquiredhyponatraemia: why
are there still deaths? Pediatrics 2004; 113(5): 1395-6.
5. McVeigh G. Management of hyperkalaemia in adults.
UlsterMedJ2005; 74(2): 75-77.
C) The Ulster Medical Society, 2005. www.ums.ac.uk